• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马来酸噻吗洛尔中3-S-杂质的合成与表征

Synthesis and Characterization of 3-S-impurities in Timolol Maleate.

作者信息

Zhou Dejun, Wang Keyang, Zhang Yuying, Liu Xiaoyue, Mao Xiaoxia

机构信息

The key Laboratory of Chinese Medicine Research and Development in Hebei Province, Traditional Chinese Medicine Institute of Chengde Medical University, Chengde, 067000, China.

Shandong Daguan Pharmaceutical Technology Co Ltd, Jinan, Shandong, 250100, China.

出版信息

Curr Org Synth. 2025;22(5):614-619. doi: 10.2174/0115701794344307241027093947.

DOI:10.2174/0115701794344307241027093947
PMID:39901554
Abstract

BACKGROUND

Timolol maleate is clinically used for the treatment of hypertension, angina pectoris, tachycardia, and glaucoma.

OBJECTIVE

The aim of this study was to enhance the safe use of timolol maleate and investigate a synthesis method for 3-S-timolol, a newly identified impurity in timolol API (Active Pharmaceutical Ingredients).

METHODS

(S)-3-(tert-butylamino)propane-1,2-diol (1) was used as a raw material. 3-S-timolol maleate (7) was synthesized through a five-step reaction. Overall yield was 57.7%, with a purity of 98%.

RESULTS

The structure of the target compound was confirmed analysis of its H nuclear magnetic resonance, C nuclear magnetic resonance, and high-resolution mass spectrometry spectra.

CONCLUSION

The synthesis method was straightforward and yielded a high-purity product suitable for use as a reference in the analysis and identification of timolol maleate-related substances.

摘要

背景

马来酸噻吗洛尔临床上用于治疗高血压、心绞痛、心动过速和青光眼。

目的

本研究旨在提高马来酸噻吗洛尔的安全使用,并研究噻吗洛尔原料药(活性药物成分)中新鉴定出的杂质3 - S - 噻吗洛尔的合成方法。

方法

以(S)-3 - (叔丁基氨基)丙烷 - 1,2 - 二醇(1)为原料。通过五步反应合成马来酸3 - S - 噻吗洛尔(7)。总收率为57.7%,纯度为98%。

结果

通过对目标化合物的氢核磁共振、碳核磁共振和高分辨率质谱光谱分析,确认了其结构。

结论

该合成方法简便,得到了高纯度产物,适用于作为马来酸噻吗洛尔相关物质分析和鉴定的对照品。

相似文献

1
Synthesis and Characterization of 3-S-impurities in Timolol Maleate.马来酸噻吗洛尔中3-S-杂质的合成与表征
Curr Org Synth. 2025;22(5):614-619. doi: 10.2174/0115701794344307241027093947.
2
Interventions for infantile haemangiomas of the skin.皮肤婴儿血管瘤的干预措施。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD006545. doi: 10.1002/14651858.CD006545.pub3.
3
Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangiomas.马来酸噻吗洛尔 0.5%水凝胶局部治疗表浅婴幼儿血管瘤。
J Drugs Dermatol. 2023 Jun 1;22(6):594-598. doi: 10.36849/JDD.7054.
4
Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.Rho 激酶抑制剂治疗原发性开角型青光眼和高眼压症。
Cochrane Database Syst Rev. 2022 Jun 10;6(6):CD013817. doi: 10.1002/14651858.CD013817.pub2.
5
Neuroprotection for treatment of glaucoma in adults.用于治疗成人青光眼的神经保护作用。
Cochrane Database Syst Rev. 2013 Feb 28;2(2):CD006539. doi: 10.1002/14651858.CD006539.pub3.
6
Neuroprotection for treatment of glaucoma in adults.用于治疗成人青光眼的神经保护。
Cochrane Database Syst Rev. 2017 Jan 25;1(1):CD006539. doi: 10.1002/14651858.CD006539.pub4.
7
Sepetaprost 0.002% Noninferiority vs. Timolol 0.5% in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: ANGEL-2.原发性开角型青光眼或高眼压症患者中0.002%司普他前列素与0.5%噻吗洛尔的非劣效性比较:ANGEL-2研究
Ophthalmol Glaucoma. 2025 Jul-Aug;8(4):384-392. doi: 10.1016/j.ogla.2025.02.004. Epub 2025 Mar 4.
8
A water-soluble drug nanoparticle-loaded in situ gel for enhanced precorneal retention and its transduction mechanism of pharmacodynamic effects.一种用于增强角膜前滞留的载水溶性药物纳米颗粒原位凝胶及其药效学作用的转导机制。
Int J Pharm. 2025 Feb 10;670:125150. doi: 10.1016/j.ijpharm.2024.125150. Epub 2024 Dec 31.
9
[Development of conjunctival hyperemia with the use of a fixed combination of latanoprost/timolol: systematic review and meta-analysis of clinical trials].
Arch Soc Esp Oftalmol. 2009 Apr;84(4):199-207. doi: 10.4321/s0365-66912009000400006.
10
Efficacy and safety of combined fractional carbon dioxide laser and topical timolol maleate 0.5% solution versus topical timolol maleate 0.5% solution alone in inflammatory facial acne; a randomized split face controlled study.联合分次二氧化碳激光与0.5%马来酸噻吗洛尔溶液对比单用0.5%马来酸噻吗洛尔溶液治疗炎性面部痤疮的疗效和安全性:一项随机半脸对照研究
Lasers Med Sci. 2025 Feb 1;40(1):58. doi: 10.1007/s10103-025-04308-y.

本文引用的文献

1
Nasally Delivered 0.5% Timolol Beta Blocker Successfully Treats Acute Migraines in a Referral Headache Clinic: A Case Series.经鼻给予 0.5%噻吗洛尔β受体阻滞剂成功治疗转诊头痛诊所的急性偏头痛:病例系列。
Mo Med. 2024 Jan-Feb;121(1):33-36.
2
First World Literature Report: Attention Pharma & Headache Researchers! Nasal Spray Timolol May Be the Next Great Thing for Acute Migraine.《第一份世界文学报告:制药与头痛研究人员请注意!鼻腔喷雾噻吗洛尔可能成为急性偏头痛的下一个重大突破。》
Mo Med. 2024 Jan-Feb;121(1):4-5.
3
Efficacy of 0.5% timolol maleate gel in the management of infantile hemangiomas.
0.5%马来酸噻吗洛尔凝胶治疗婴幼儿血管瘤的疗效
Pak J Med Sci. 2024 Jan;40(2ICON Suppl):S75-S79. doi: 10.12669/pjms.40.2(ICON).8983.
4
Efficacy of timolol in the treatment of facial hemangioma and its effect on the proliferation and apoptosis of hemangioma stem cells.噻吗洛尔治疗面部血管瘤的疗效及其对血管瘤干细胞增殖和凋亡的影响。
Cell Mol Biol (Noisy-le-grand). 2023 Oct 31;69(10):115-120. doi: 10.14715/cmb/2023.69.10.16.
5
Treatment of Hydroxyurea-Induced Ulcers With Timolol.
JAMA Dermatol. 2023 Nov 1;159(11):1277-1279. doi: 10.1001/jamadermatol.2023.2765.
6
Topical timolol 0.5% as a novel therapeutic approach for Hailey-Hailey disease.
Clin Exp Dermatol. 2023 Dec 19;49(1):76-78. doi: 10.1093/ced/llad296.
7
COVID-19-associated diffuse dermal angiomatosis managed with pentoxifylline and topical timolol.采用己酮可可碱和局部用噻吗洛尔治疗的新型冠状病毒肺炎相关弥漫性皮肤血管瘤病
JAAD Case Rep. 2023 Jul 14;39:34-36. doi: 10.1016/j.jdcr.2023.07.002. eCollection 2023 Sep.
8
Activation of ADRB2/PKA Signaling Pathway Facilitates Lipid Synthesis in Meibocytes, and Beta-Blocker Glaucoma Drug Impedes PKA-Induced Lipid Synthesis by Inhibiting ADRB2.ADRB2/PKA 信号通路的激活促进了眼胞中的脂质合成,而β受体阻滞剂类青光眼药物通过抑制 ADRB2 来阻碍 PKA 诱导的脂质合成。
Int J Mol Sci. 2022 Aug 22;23(16):9478. doi: 10.3390/ijms23169478.
9
Bradycardia From a Non-selective Beta-Adrenergic Antagonist, Timolol, Applied Ophthalmologically for Glaucoma.局部应用于青光眼治疗的非选择性β肾上腺素能拮抗剂噻吗洛尔所致的心动过缓
Cureus. 2022 Jun 10;14(6):e25815. doi: 10.7759/cureus.25815. eCollection 2022 Jun.
10
Rapid Involution of Presumed Pyogenic Granuloma with Topical Timolol.
Ophthalmology. 2023 Jan;130(1):27. doi: 10.1016/j.ophtha.2022.04.019. Epub 2022 Jun 28.